Navigation Links
23 researchers join network of EMBO Young Investigators
Date:11/6/2013

HEIDELBERG, 6 NOVEMBER 2013 EMBO announced today the selection of 23 young researchers as EMBO Young Investigators. The scientists join a network of 315 current and past Young Investigators.

The Young Investigator Programme is for researchers under forty years of age who have established their first laboratories in the past four years. The successful candidates work in ten European countries, Israel and Singapore. The success rate for selection to this highly competitive programme was twelve per cent this year.

"The newly elected EMBO Young Investigators have the potential to be tomorrow's life science leaders," says Gerlind Wallon, EMBO Deputy Director and Manager of the Young Investigator Programme. "The status of Young Investigator offers a level of recognition that brings immediate benefits to scientists at an early stage of their careers."

Financial support includes 15,000 euros per year for three years directly from the member state where the laboratories of the scientists are located. The researchers receive a range of benefits to help start their first independent research laboratories. Laboratory management and non-scientific skills training as well as PhD courses offer the young group leaders and their students the chance to develop professional skills. The scientists also receive access to core facilities at EMBL and funding for themselves and their group members to attend conferences.


'/>"/>

Contact: Barry Whyte
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Page: 1

Related biology news :

1. Breakthrough by Temple researchers could lead to new treatment for heart attack
2. Temple researchers uncover clues to how existing heart drugs work
3. Researchers unmask centuries-old elephant imposter
4. Virginia Tech researchers explore natural way to displace harmful germs from household plumbing
5. Penn researchers identify molecular link between gut microbes and intestinal health
6. Researchers Able to Identify that Benign Tumors from Use of Oral Contraceptive Have a Greater Chance of Becoming Malignant
7. Children of lower socioeconomic status grow up more susceptible to catching colds, Carnegie Mellon researchers find
8. University of Louisville researchers sign global licensing agreement
9. BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy
10. Researchers quantify toxic ocean conditions during major extinction 93.9 million years ago
11. Researchers discover how cancer invisibility cloak works
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... 20, 2016 The rising popularity of ... leasing is stoking significant interest in keyless access ... Bluetooth low energy (BLE), biometrics and near-field communication ... wave of wireless technologies in the automotive industry. ... advanced access systems opens the market to specialist ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 19, 2017 Research and Markets ... has announced the addition of the ... Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market trends ... using estimated market values as the base numbers Key ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 /PRNewswire/ ... a privately-held immunotherapeutics company targeting infectious diseases, announced ... the merger of PharmAthene and Altimmune in an ... Fund, HealthCap, Truffle Capital and Redmont Capital. The ... immunotherapeutics company with four clinical stage and one ...
(Date:1/19/2017)... , ... January 18, 2017 , ... ... Institutes of Health (NIH) to update its Data Sharing Policy. Specifically, the nation’s ... of grant applications subject to the existing policy. AMIA recommended that NIH earmark ...
(Date:1/19/2017)... ... 2017 , ... DaVita Clinical Research (DCR), a ... device development, and Prism Clinical Research , a leader in providing fully ... Clinical Trials (VCT) has been selected by both companies as an exclusive ...
Breaking Biology Technology: